Your browser doesn't support javascript.
Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2.
Manganotti, Paolo; Pesavento, Valentina; Buoite Stella, Alex; Bonzi, Lucia; Campagnolo, Elena; Bellavita, Giulia; Fabris, Bruno; Luzzati, Roberto.
  • Manganotti P; Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Cattinara University Hospital ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy. pmanganotti@units.it.
  • Pesavento V; Rehabilitation Unit, Cattinara University Hospital ASUGI, Via Giuseppe Lorenzo Gatteri, 25/1, 34125, Trieste, Italy.
  • Buoite Stella A; Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Cattinara University Hospital ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
  • Bonzi L; Rehabilitation Unit, Cattinara University Hospital ASUGI, Via Giuseppe Lorenzo Gatteri, 25/1, 34125, Trieste, Italy.
  • Campagnolo E; Endocrinology Unit, Department of Medicine, Surgery and Health Sciences, Cattinara University Hospital ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
  • Bellavita G; Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Cattinara University Hospital ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
  • Fabris B; Endocrinology Unit, Department of Medicine, Surgery and Health Sciences, Cattinara University Hospital ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
  • Luzzati R; Infectious Diseases Department, Department of Medicine, Surgery and Health Sciences, Cattinara University Hospital ASUGI, University of Trieste, Strada di Fiume, 447, 34149, Trieste, Italy.
J Neurovirol ; 26(4): 605-606, 2020 08.
Article in English | MEDLINE | ID: covidwho-593343
ABSTRACT
This case report describes the clinical characteristics of a 50-year-old woman that developed SARS-CoV-2 pneumonia and was admitted at the COVID-19 dedicated unit where she developed neurological symptoms 10 days after admission. After neurological examination, including a panel of blood cerebrospinal fluid biomarkers, a diagnosis of Miller Fisher syndrome (MFS) was hypothesized and intravenous immunoglobulin therapy (IVIG) was initiated. Fourteen days after the start of IVIG treatment, the patient has been discharged at home with the resolution of respiratory symptoms and only minor hyporeflexia at the lower limbs, without any side effect.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Immunoglobulins, Intravenous / Coronavirus Infections / Miller Fisher Syndrome Type of study: Case report / Prognostic study Topics: Long Covid / Variants Limits: Female / Humans / Middle aged Language: English Journal: J Neurovirol Journal subject: Neurology / Virology Year: 2020 Document Type: Article Affiliation country: S13365-020-00858-9

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Immunoglobulins, Intravenous / Coronavirus Infections / Miller Fisher Syndrome Type of study: Case report / Prognostic study Topics: Long Covid / Variants Limits: Female / Humans / Middle aged Language: English Journal: J Neurovirol Journal subject: Neurology / Virology Year: 2020 Document Type: Article Affiliation country: S13365-020-00858-9